Evaluation of the Mayo Additive Staging System in patients with newly diagnosed multiple myeloma: A real-world analysis

被引:3
作者
Chen, Haimin [1 ]
Shi, Haotian [1 ]
Zhou, Nian [1 ]
Yu, Wenjun [1 ]
Wu, Lixia [1 ]
Peng, Rong [1 ]
Wei, Wei [1 ]
Wang, Dongjiao [1 ]
Zhou, Fan [1 ]
机构
[1] Shanghai Jingan Dist Zhabei Cent Hosp, Dept Hematol & Oncol, 619 Zhonghua New Rd, Shanghai 200070, Peoples R China
基金
中国国家自然科学基金;
关键词
Mayo Additive Staging System; multiple myeloma; overall survival; progression-free survival; risk stratification; FISH;
D O I
10.1111/ejh.13897
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Recently, the Mayo Clinic introduced a new staging system (the Mayo Additive Staging System [MASS]) for patients with newly diagnosed multiple myeloma (NDMM) based on the number of high-risk (HR) abnormalities, including HR IgH translocations, 1q gain/amplification, chromosome 17 abnormalities, International Staging System (ISS)-III, and elevated lactate dehydrogenase. Patients with 0, 1, or >= 2 HR abnormalities were defined as stage I, II, or III, respectively. We aimed to validate the real-world prognostic value of the MASS. Methods: We retrospectively analyzed the cytogenetic and laboratory results of 544 patients with NDMM at a single center. Results: Ninety (16.5%) patients had no HR factors (MASS I), 193 (35.5%) had 1 HR factor (MASS II), and 261 (48%) had >= 2 HR factors (MASS III). The median progression-free survival (PFS) and overall survival (OS) times were 48, 28, and 20 months and 137, 73, and 39 months in the three groups, respectively (p < .001). In the subgroup analysis, patients had different OS outcomes based on the MASS when grouped by age, renal function, or therapeutic regimens. The MASS identified patients with the worst outcomes among those rated revised ISS II. Conclusion: The MASS system is a reliable risk stratification tool for patients with NDMM in real-world clinical practice.
引用
收藏
页码:229 / 235
页数:7
相关论文
共 17 条
[1]   A simple additive staging system for newly diagnosed multiple myeloma [J].
Abdallah, Nadine H. ;
Binder, Moritz ;
Rajkumar, S. Vincent ;
Greipp, Patricia T. ;
Kapoor, Prashant ;
Dispenzieri, Angela ;
Gertz, Morie A. ;
Baughn, Linda B. ;
Lacy, Martha Q. ;
Hayman, Suzanne R. ;
Buadi, Francis K. ;
Dingli, David ;
Go, Ronald S. ;
Hwa, Yi L. ;
Fonder, Amie L. ;
Hobbs, Miriam A. ;
Lin, Yi ;
Leung, Nelson ;
Kourelis, Taxiarchis ;
Warsame, Rahma ;
Siddiqui, Mustaqeem A. ;
Kyle, Robert A. ;
Bergsagel, P. Leif ;
Fonseca, Rafael ;
Ketterling, Rhett P. ;
Kumar, Shaji K. .
BLOOD CANCER JOURNAL, 2022, 12 (01)
[2]   Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance [J].
Baysal, Mehmet ;
Demirci, Ufuk ;
Umit, Elif ;
Kirkizlar, Hakki Onur ;
Atli, Emine Ikbal ;
Gurkan, Hakan ;
Gulsaran, Sedanur Karaman ;
Bas, Volkan ;
Mail, Cisem ;
Demir, Ahmet Muzaffer .
SCIENTIFIC REPORTS, 2020, 10 (01)
[3]   Understanding Biology to Tackle the Disease: Multiple Myeloma From Bench to Bedside, and Back [J].
Bianchi, Giada ;
Anderson, Kenneth C. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (06) :422-444
[4]   A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial [J].
Boyd, K. D. ;
Ross, F. M. ;
Chiecchio, L. ;
Dagrada, G. P. ;
Konn, Z. J. ;
Tapper, W. J. ;
Walker, B. A. ;
Wardell, C. P. ;
Gregory, W. M. ;
Szubert, A. J. ;
Bell, S. E. ;
Child, J. A. ;
Jackson, G. H. ;
Davies, F. E. ;
Morgan, G. J. .
LEUKEMIA, 2012, 26 (02) :349-355
[5]   Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets [J].
Burroughs Garcia, Jessica ;
Eufemiese, Rosa Alba ;
Storti, Paola ;
Sammarelli, Gabriella ;
Craviotto, Luisa ;
Todaro, Giannalisa ;
Toscani, Denise ;
Marchica, Valentina ;
Giuliani, Nicola .
CELLS, 2021, 10 (06)
[6]   Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT) [J].
Durie, Brian G. M. ;
Hoering, Antje ;
Sexton, Rachael ;
Abidi, Muneer H. ;
Epstein, Joshua ;
Rajkumar, S. Vincent ;
Dispenzieri, Angela ;
Kahanic, Stephen P. ;
Thakuri, Mohan C. ;
Reu, Frederic J. ;
Reynolds, Christopher M. ;
Orlowski, Robert Z. ;
Barlogie, Bart .
BLOOD CANCER JOURNAL, 2020, 10 (05)
[7]   International Myeloma Working Group molecular classification of multiple myeloma: spotlight review [J].
Fonseca, R. ;
Bergsagel, P. L. ;
Drach, J. ;
Shaughnessy, J. ;
Gutierrez, N. ;
Stewart, A. K. ;
Morgan, G. ;
Van Ness, B. ;
Chesi, M. ;
Minvielle, S. ;
Neri, A. ;
Barlogie, B. ;
Kuehl, W. M. ;
Liebisch, P. ;
Davies, F. ;
Chen-Kiang, S. ;
Durie, B. G. M. ;
Carrasco, R. ;
Sezer, Orhan ;
Reiman, Tony ;
Pilarski, Linda ;
Avet-Loiseau, H. .
LEUKEMIA, 2009, 23 (12) :2210-2221
[8]   International staging system for multiple myeloma [J].
Greipp, PR ;
San Miguel, J ;
Durie, BGM ;
Crowley, JJ ;
Barlogie, B ;
Bladé, J ;
Boccadoro, M ;
Child, JA ;
Harousseau, JL ;
Kyle, RA ;
Lahuerta, JJ ;
Ludwig, H ;
Morgan, G ;
Powles, R ;
Shimizu, K ;
Shustik, C ;
Sonneveld, P ;
Tosi, P ;
Turesson, I ;
Westin, J .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3412-3420
[9]   Clinical features and treatment outcome in newly diagnosed Chinese patients with multiple myeloma: results of a multicenter analysis [J].
Lu, J. ;
Lu, J. ;
Chen, W. ;
Huo, Y. ;
Huang, X. ;
Hou, J. .
BLOOD CANCER JOURNAL, 2014, 4 :e239-e239
[10]   Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group [J].
Palumbo, Antonio ;
Avet-Loiseau, Herve ;
Oliva, Stefania ;
Lokhorst, Henk M. ;
Goldschmidt, Hartmut ;
Rosinol, Laura ;
Richardson, Paul ;
Caltagirone, Simona ;
Jose Lahuerta, Juan ;
Facon, Thierry ;
Bringhen, Sara ;
Gay, Francesca ;
Attal, Michel ;
Passera, Roberto ;
Spencer, Andrew ;
Offidani, Massimo ;
Kumar, Shaji ;
Musto, Pellegrino ;
Lonial, Sagar ;
Petrucci, Maria T. ;
Orlowski, Robert Z. ;
Zamagni, Elena ;
Morgan, Gareth ;
Dimopoulos, Meletios A. ;
Durie, Brian G. M. ;
Anderson, Kenneth C. ;
Sonneveld, Pieter ;
San Miguel, Jesus ;
Cavo, Michele ;
Rajkumar, S. Vincent ;
Moreau, Philippe .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (26) :2863-+